By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous topical agents > Vaniqa
Miscellaneous topical agents

Vaniqa

https://themeditary.com/drug/vaniqa-3903.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 05, 2023  Additional Content by TheMediTary.Com

Generic name: eflornithine topical [ ee-floor-nih-theen ]

Drug class: Miscellaneous topical agents

Dosage form: cream

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Eflornithine (monograph), Eflornithine topical

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Vaniqa?

Vaniqa interferes with a chemical in hair follicles under the skin, which slows hair growth where the medicine is applied.

Vaniqa cream is used to reduce unwanted facial hair in women.

Vaniqa cream does not permanently remove facial hair or prevent hair growth.

Warnings

Vaniqa cream is for external use only.

Continue to use Vaniqa even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment.

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

You should not use Vaniqa cream if you have had an allergic reaction to eflornithine in the past.

It is not known whether Vaniqa cream will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether eflornithine topical passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Vaniqa is not approved for use by anyone younger than 12 years old.

Vaniqa pregnancy and breastfeeding warnings (more detail)

How should I take Vaniqa

Apply Vaniqa cream exactly as directed by your doctor. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.

Do not take by mouth. Topical medicine is for use only on the skin. Do not use on open wounds or on sunburned, windburned, dry, chapped, or irritated skin.

Vaniqa cream is usually applied twice daily, at least 8 hours apart. This medicine is for use only on the face and chin. Do not apply to other areas of the body.

Before application, remove any facial hair using your desired hair removal method (razor, tweezers, etc). Wait at least 5 minutes before applying Vaniqa.

Wash your hands before and after applying the medicine.

Apply a thin layer of cream to all affected areas of the face or under the chin and rub in thoroughly.

Wait until the medicine dries completely before you apply cosmetics or sunscreen to treated areas.

Do not wash the treatment areas for at least 4 hours after application of Vaniqa.

If this medicine irritates your skin, you may need to reduce applications to once daily.

Call your doctor if skin irritation does not improve, or if it gets worse.

Vaniqa cream is not a hair remover (depilatory). You will need to continue using your current hair removal techniques. This medicine can help you manage your condition and improve your appearance.

Vaniqa will reduce facial hair growth gradually. Keep using the medicine even if you do not see immediate results. It may take 4 to 8 weeks or longer before you notice improvement.

Stop using this medicine if you do not get the desired results after 6 months of use.

Store at room temperature away from moisture and heat. Do not allow the medicine to freeze.

Hair growth may return to pretreatment levels approximately 8 weeks after you stop using Vaniqa.

Dosing information

Usual Adult Dose for Hirsutism:

Apply a thin layer of Vaniqa cream to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice a day, allowing at least 8 hours between applications or as directed by a physician.

Continue to use hair removal techniques as needed in conjunction with eflornithine. Apply eflornithine at least 5 minutes after hair removal. Cosmetics or sunscreens may be applied over treated areas after cream has dried.

Detailed Vaniqa dosage information
Vaniqa Dosage information (more detail)

Before Taking

You should not use Vaniqa cream if you have had an allergic reaction to eflornithine in the past.

It is not known whether Vaniqa cream will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether eflornithine topical passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Vaniqa is not approved for use by anyone younger than 12 years old.

Vaniqa pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

spironolactone, Aldactone, flutamide, Florexa, Eulexin, eflornithine topical

What happens if I miss a dose?

Apply the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

An overdose of Vaniqa cream is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medication.

What should I avoid while using Vaniqa?

If the medicine gets in your eyes, rinse thoroughly with water and contact your doctor.

Vaniqa side effects

Get emergency medical help if you have signs of an allergic reaction to Vaniqa cream : hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using eflornithine and call your doctor at once if you have:

  • severe irritation of treated skin; or

  • redness or crusting around your hair follicles.

Common Vaniqa side effects may include:

  • temporary redness, rash, burning, stinging, itching, or tingling;

  • acne or red bumps on the skin;

  • skin dryness; or

  • headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Vaniqa Side Effects

More about Vaniqa (Eflornithine topical [ ee-floor-nih-theen ])

Dosage information
Vaniqa Side Effects
During pregnancy
Florexa Cream Prescribing Information
Drug images
Side effects
Drug class: Miscellaneous topical agents

Related treatment guides

Hirsutism
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by